Capsida Biotherapeutics to Present New Preclinical Data on Potential of Systemically Delivered Next-Generation AAV Therapeutics for Treatment of Genetic Epilepsy
Three Key Insights On The Medical Equipment Industry 2023-2032, By The Global Market Model
Illumina’s Board of Directors elects two experienced Independent Directors to Board
Dragonfly Therapeutics to Present Phase 1 DF1001 Monotherapy Dose Escalation Results at ASCO 2023 Annual Meeting
WELL Health to Participate at Eight Capital innoVIII: AI: Theory to Commerciality Conference
America’s Best Wings: Everything You Need to Know
Covid-19: the study which establishes a link between severe form and cancer
Exercise for stronger bones
Death of Guillaume Bats: what is the glass bone disease from which the comedian suffered?
a severe form could be a predictive marker of cancer
Genetics partly explains a form of heart attack affecting mainly women
Preclinical data show IV administration of a next-generation gene therapy produced dose-dependent replacement of syntaxin-binding protein 1 (STXBP1) throughout the brain, with efficacy predictive of clinical...